Pharmaceutical Industry: What You Should Know About the New BCRA Communication “A” 7507 - Ally Latinx

Richards Cardinal Tützer Zabala Zaefferer
May 9, 2022

Pharmaceutical Industry: What You Should Know About the New BCRA Communication “A” 7507

BCRA broadens exceptions for payment of imports of pharmaceutical products and/or its supplies for local manufacturing. MORE

Share

Related News

Positive Administrative Silence in Procedures Before the Administration

New Law 27,786: Impact on Companies in the Technology and Telecommunications Sector

Restrictions on Approval of Economic Clauses in Collective Agreements